Please find attached herewith the Annual Secretarial Compliance Report for the F.Y. ended 31st March, 2026.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals has submitted its Annual Secretarial Compliance Report for FY 2025-26, certified by Practicing Company Secretaries Samdani Shah & Kabra. The report covers compliance with multiple SEBI regulations including SEBI LODR, SAST, PIT, and Depositories regulations. All 13 compliance checkpoints assessed in Annexure III returned 'Yes' or 'NA', indicating full compliance. No deviations or violations were found (Annexure I — NIL), and no unresolved observations from prior reports exist (Annexure II — Not Applicable). No actions were taken against the company by SEBI or stock exchanges during the review period.
Clean compliance report with no adverse findings — this is a routine regulatory filing with no direct impact on the stock. Confirms the company maintained good governance and regulatory standing throughout the year.